TRF (TRF)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹230.71 |
| Market Cap | ₹253.88 Cr |
| P/E Ratio | 16.89 |
| ROCE | 21.81% |
| ROE | -5.33% |
| Dividend Yield | 0% |
| Profit Growth | -65.79% |
| Debt/Equity | 1.54 |
| Sales Growth | 20.85% |
| Promoter Holding | 34.12% |
| 52-Week Range | ₹215 — ₹405 |
| Sector | Industrial Manufacturing |
| Book Value | ₹58.72 |
Strengths
- Reported ROE of 23.66% and ROCE of 21.81% show efficient recent use of capital.
- Latest quarter earned ₹6 Cr net profit on ₹20 Cr sales, indicating margin resilience despite top-line pressure.
- Price of ₹265.12 is near the lower end of the 52-week range of ₹215.50-₹405.00, reducing some downside versus the recent peak.
- P/E of 16.89 is not extreme if earnings can stabilize, though that is a big 'if'.
Concerns
- Sales declined 14.67% and profit collapsed 48.36%, showing sharp deterioration in business momentum.
- Piotroski F-Score of 3/9 signals weak financial health and possible operational stress.
- Debt/Equity of 1.44 is high; the strong ROE may be leveraged and vulnerable in a slowdown.
- Zero dividend and promoter holding of 34.12% limit minority shareholder returns and alignment.
AI Analysis
At first glance, TRF's 23.66% ROE and 21.81% ROCE catch my eye. But I have learned to look behind the ratios. A 14.67% fall in sales and a 48.36% collapse in profit are not signs of a durable franchise. The Piotroski F-Score of 3 out of 9 reinforces my caution: this is a company under financial stress, not one with improving fundamentals. The balance sheet shows debt/equity of 1.44, so that ROE is partly borrowed, not pure earning power. In Graham's language, a high return on equity is only meaningful if it can be maintained without excessive leverage and through a full cycle. The latest quarter offers a small spark: sales of ₹20 Cr and net profit of ₹6 Cr implies a healthy profit margin. But one quarter cannot undo a year of declining top line, and with no dividend, I as a minority shareholder receive no cash while waiting. At ₹265.12, the stock trades at 16.89 times earnings and 4.51 times book value. Book value is only ₹58.72. That is a rich price for a business whose earnings are falling. The 52-week range tells me the market has already repriced it from ₹405 to ₹265, but a falling knife still hurts. I also note promoter holding is 34.12%, which is not very strong alignment; in Indian industrials, I prefer owners to have more skin in the game. The FairStock score is unavailable due to insufficient data. For a value investor, inadequate information is itself a red flag. TRF may be a cyclical business near a low, but I cannot say it is a clear bargain. I want a margin of safety. With high debt, weak F-Score, zero dividend, and declining growth, TRF fails that test. I would wait for either a stronger balance sheet, consistent margin improvement, or a significantly lower price before acting.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer